Zobrazeno 1 - 6
of 6
pro vyhledávání: '"i.t., intratumoral"'
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 10, Iss 12, Pp 2272-2298 (2020)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Multiple cancer immunotherapies including chimeric antigen receptor T cell and immune checkpoint inhibitors (ICIs) have been successfully developed to treat various cancers by motivating the adaptive anti-tumor immunity. Particularly, the checkpoint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c604607610f05b2d37da5b2cce00382
http://www.sciencedirect.com/science/article/pii/S2211383519316946
http://www.sciencedirect.com/science/article/pii/S2211383519316946
Autor:
Guy Ungerechts, Mathias F. Leber, Russell Barkley, John C. Bell, Serge Neault, Elise Jirovec, Aida Said
Publikováno v:
Cytokine & Growth Factor Reviews
Graphical abstract
Highlights • Vaccine strain-derived measles viruses are promising oncolytic immunotherapeutics. • They have an excellent safety record and can be genetically engineered on multiple levels for superior therapeutic efficacy
Highlights • Vaccine strain-derived measles viruses are promising oncolytic immunotherapeutics. • They have an excellent safety record and can be genetically engineered on multiple levels for superior therapeutic efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52eac8c05437b2e621246bdba847551e
https://pubmed.ncbi.nlm.nih.gov/32718830
https://pubmed.ncbi.nlm.nih.gov/32718830
Publikováno v:
Cancer Letters
Oncolytic virotherapy is a promising form of gene therapy for cancer, employing nature's own agents to find and destroy malignant cells. The purpose of this review is to provide an introduction to this very topical field of research and to point out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f5e7d8ea21ecab5cbd61be9399eb8ee
https://pubmed.ncbi.nlm.nih.gov/17383089
https://pubmed.ncbi.nlm.nih.gov/17383089
Autor:
Sruthi Ravindranathan, Sean G. Smith, David A. Zaharoff, Bhanu prasanth Koppolu, Jimmy Ln Vo, Samantha L. Kurtz, Lirong Yang
Publikováno v:
Oncoimmunology
Metastasis accounts for approximately 90% of breast cancer-related deaths. Therefore, novel approaches which prevent or control breast cancer metastases are of significant clinical interest. Interleukin-12 (IL-12)-based immunotherapies have shown pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422047d280c89cfa81fd40f177bf294d
https://doi.org/10.4161/21624011.2014.968001
https://doi.org/10.4161/21624011.2014.968001
Autor:
Ding C; Research Laboratory of Medicinal Chemical Biology & Frontiers on Drug Discovery (RLMCBFDD), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Song Z; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Shen A; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Chen T; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Zhang A; Research Laboratory of Medicinal Chemical Biology & Frontiers on Drug Discovery (RLMCBFDD), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.; CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.
Publikováno v:
Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2020 Dec; Vol. 10 (12), pp. 2272-2298. Date of Electronic Publication: 2020 Mar 13.
Autor:
Vo JL; Department of Biomedical Engineering; University of Arkansas ; Fayetteville, AR USA., Yang L; Department of Biomedical Engineering; University of Arkansas ; Fayetteville, AR USA., Kurtz SL; Department of Biomedical Engineering; University of Arkansas ; Fayetteville, AR USA., Smith SG; Department of Biomedical Engineering; University of Arkansas ; Fayetteville, AR USA., Koppolu BP; Department of Biomedical Engineering; University of Arkansas ; Fayetteville, AR USA., Ravindranathan S; Department of Biomedical Engineering; University of Arkansas ; Fayetteville, AR USA., Zaharoff DA; Department of Biomedical Engineering; University of Arkansas ; Fayetteville, AR USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2015 Jan 07; Vol. 3 (12), pp. e968001. Date of Electronic Publication: 2015 Jan 07 (Print Publication: 2014).